Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Depreciation & Amortization (CF) (2020)

Silo Pharma's Depreciation & Amortization (CF) history spans 1 years, with the latest figure at $185625.0 for Q2 2020.

  • For Q2 2020, Depreciation & Amortization (CF) changed N/A year-over-year to $185625.0; the TTM value through Mar 2021 reached $185625.0, up 125.0%, while the annual FY2020 figure was $268125.0, 333.33% up from the prior year.
  • Depreciation & Amortization (CF) for Q2 2020 was $185625.0 at Silo Pharma, up from $82500.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $185625.0 in Q2 2020 and bottomed at $82500.0 in Q1 2020.